EPL (500135) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
8 Jul, 2026Executive summary
Achieved double-digit revenue growth of 10.7% year-over-year, with EBITDA up 20.8% and adjusted PAT up 35.4%, supported by strong regional contributions.
EBITDA margin expanded to 19.1%, a 160 bps improvement year-over-year.
ROCE improved to 15.9%, up 1.9 percentage points year-over-year.
Growth driven by robust demand, innovation, and sustainability initiatives, with recognition at industry awards.
Unaudited financial results for the quarter ended June 30, 2024, were approved with no material misstatements.
Financial highlights
Revenue from operations reached INR 10,074 million, up 10.7% YoY; EBITDA at INR 1,921 million, up 20.8% YoY.
Adjusted PAT up 35.4% YoY; reported PAT up 18.2% YoY; consolidated net profit after tax was ₹264 million, up from ₹154 million.
EBITDA margin at 19.1%, up 160 bps YoY.
Net debt reduced to INR 5,039 million from INR 6,026 million as of Mar 24; Net Debt/EBITDA improved to 0.67x.
Capex for Q1FY25 was INR 442 million.
Outlook and guidance
Targeting sustained double-digit revenue growth and EBITDA margins above 20%.
Aggressive expansion in 'Personal Care & Beyond' and scaling up Brazil operations.
Continued focus on sustainability, automation, and margin expansion.
Acquired 49% stake in Clean Max Aria Private Limited post-quarter for captive wind and solar power.
No major price corrections pending; pricing environment expected to stabilize.
Latest events from EPL
- Q1FY27 revenue up 25.3% to INR 13,879m, EBITDA up 15.2%, Indovida merger progressing.500135
Q1 26/27 - Q4FY26 saw 17.6% revenue growth, strong margins, and a major merger to drive future gains.500135
Q4 25/26 - $1B merger forms an emerging markets packaging leader with major synergies and global reach.500135
M&A announcement - Double-digit revenue and EBITDA growth, led by beauty and cosmetics, with improved ROCE.500135
Q3 25/26 - Double-digit revenue and profit growth, margin expansion, and interim dividend declared.500135
Q2 25/26 - Double-digit growth, margin expansion, and strong beauty/cosmetics momentum drive outlook.500135
Q1 25/26 - Q2 FY25 saw strong growth, margin expansion, and advances in sustainability and capital efficiency.500135
Q2 24/25 - Strong FY25 growth, margin expansion, dividend declared, and international expansion underway.500135
Q4 24/25 - EBITDA margin hit 20.3% with robust profit growth and expansion in key segments.500135
Q3 24/25